Zobrazeno 1 - 10
of 229
pro vyhledávání: '"Drug Review"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Objective:Since 2016, China has successively implemented Accelerated Drug Marketing Registration Procedures (ADMRPs) for drugs, including Breakthrough Therapy Drug (BTD), Conditional Approval (CA), and Priority Review and Approval (PRA), which have p
Externí odkaz:
https://doaj.org/article/12dee75cd05341749e46fe7f85fb06f3
Autor:
Marya Hussain, Chelsea Wong, Eddy Taguedong, Saurav Verma, Md Mahsin, Safiya Karim, Richard Lee-Ying, Doreen A. Ezeife
Publikováno v:
Current Oncology, Vol 30, Iss 8, Pp 7706-7712 (2023)
New oncology drugs undergo detailed review prior to public funding in a single-payer healthcare system. The aim of this study was to assess how cancer drug review times impact funding recommendations. Drugs reviewed by the pan-Canadian Oncology Drug
Externí odkaz:
https://doaj.org/article/ee66eb7f138d488db02a69eff1e5be2d
Autor:
Siyue Song, Anju P. Johnson
Publikováno v:
IEEE Access, Vol 11, Pp 118538-118546 (2023)
The massive volume of textual data generated in recent years has led to the development of new computer-based technologies, especially in the field of healthcare area. Sentiment analysis opens a new door in healthcare to improve public health data an
Externí odkaz:
https://doaj.org/article/31b1bba87c5c4656afc1dc4fb1caf67d
Publikováno v:
Chain Drug Review. 1/15/2018, Vol. 40 Issue 2, p36-45. 8p.
Publikováno v:
Drug, Healthcare and Patient Safety, Vol Volume 13, Pp 183-210 (2021)
Hesah Alshammari, Eman Al-Saeed, Zamzam Ahmed, Zoe Aslanpour Department of Clinical and Pharmaceutical Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UKCorrespondence: Hesah Alshammari Email h.hesah-a-j-m-a-alsh
Externí odkaz:
https://doaj.org/article/9b383e5ff3554dcba769fab8aae4b05c
Publikováno v:
Current Oncology, Vol 28, Iss 1, Pp 606-618 (2021)
Background: To determine the magnitude of difference between manufacturer-submitted and pan-Canadian Oncology Drug Review (pCODR) calculated incremental cost-effectiveness ratios (ICERs), incremental cost (ΔC), and incremental effectiveness (ΔE); t
Externí odkaz:
https://doaj.org/article/8ce479d71683474bae3a1defde9e3afd
Autor:
Alexander Sboev, Roman Rybka, Anton Selivanov, Ivan Moloshnikov, Artem Gryaznov, Alexander Naumov, Sanna Sboeva, Gleb Rylkov, Soyora Zakirova
Publikováno v:
Mathematics, Vol 11, Iss 2, p 354 (2023)
An extraction of significant information from Internet sources is an important task of pharmacovigilance due to the need for post-clinical drugs monitoring. This research considers the task of end-to-end recognition of pharmaceutically significant na
Externí odkaz:
https://doaj.org/article/ebe029668f60475aa64c7f3482f810ac
Autor:
Alexander Sboev, Roman Rybka, Artem Gryaznov, Ivan Moloshnikov, Sanna Sboeva, Gleb Rylkov, Anton Selivanov
Publikováno v:
Big Data and Cognitive Computing, Vol 6, Iss 4, p 145 (2022)
Mapping the pharmaceutically significant entities on natural language to standardized terms/concepts is a key task in the development of the systems for pharmacovigilance, marketing, and using drugs out of the application scope. This work estimates t
Externí odkaz:
https://doaj.org/article/a0bc239b672440f6a92c5b408a7b0dbe
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Chain Drug Review. 1/18/2010, Vol. 32 Issue 2, p22-32. 7p. 12 Color Photographs.